Categories: Health

Director/PDMR Shareholding

 | Source: DXS International PLC

DXS INTERNATIONAL PLC

(AQSE: DXSP)

Notification of Director / PDMR Dealing

DXS INTERNATIONAL PLC

The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 30 January, Mr Bob Sutcliffe, the Chairman, purchased 15,000 Ordinary Shares in the Company at a price of 2.9p per share.

Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,253,756 Ordinary Shares representing 1.96% of the issued share capital of the Company.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Mr. Robert Sutcliffe
2 Reason for the notification
a) Position/status Chairman
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name DXS INTERNATIONAL PLC
b) LEI 2138001R1KEUWTXEVJ44
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.33p each
Identification code ISIN GB00B2Q6HZ92
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
2.9p 15,000
d) Aggregated information
– Aggregated volume
– Price
e) Date of the transaction 30 January 2025
f) Place of the transaction Aquis Stock Exchange

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman
DXS International plc
www.dxs-systems.com
01252 719800
AQSE Corporate Broker and Corporate Advisor
Hybridan LLP
Claire Louise Noyce
020 3764 2341

Notes to Editors

About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

GlobeNews Wire

Recent Posts

Asia Photonics Expo 2025: The Gateway to Photonics Innovations and Cross-Industry Collaborations

SINGAPORE, Feb. 26, 2025 /PRNewswire/ -- The 2nd edition of Asia Photonics Expo (APE) 2025…

1 hour ago

MEXC Invests $20 Million in USDe to Drive Stablecoin Adoption, Launches $1,000,000 Reward Event

VICTORIA, Seychelles, Feb. 26, 2025 /PRNewswire/ -- MEXC, the world's leading cryptocurrency trading platform, has invested…

1 hour ago

Infosys Launches Open-Source Responsible AI Toolkit to Enhance Trust and Transparency in AI

The initiative furthers Infosys' commitment to creating an inclusive AI ecosystem, ensuring safety, security, privacy,…

1 hour ago

Bybit Earn Pilots OpenAPI Integration into Flexible Savings

DUBAI, UAE, Feb. 26, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume,…

1 hour ago

Colt DCS expands hyperscale data centre footprint with Inzai 4 launch in Tokyo, Japan

The hyperscale facility marks the operator's fourth site in Inzai, enhancing Colt DCS' capacity to…

1 hour ago

Sun Life Survey Reveals Women in Asia Are More Financially Secure Than Ever, But Challenges Persist

Close to two thirds of women feel their financial security has improved compared to their…

1 hour ago